Chugai Pharma Europe Ltd Company Profile

04:01 EDT 24th March 2018 | BioPortfolio

Chugai Pharmaceutical Co., Ltd is headquartered in Tokyo, Japan. In its home market, Chugai is a household name, with a broad-ranging product portfolio encompassing highly specialised therapeutic antibody biotechnology through over-the-counter medicines to consumer healthcare products.
Chugai is currently the 5th ranked pharmaceutical company in Japan in terms of sales, (the world’s second largest pharmaceutical market after the USA).
On 1st October 2002, Chugai Pharmaceutical Co became a member of the Roche Group, and is Roche’s sole representative in Japan following the integration of Nippon Roche and Chugai.
One of the first examples of specific collaboration between Chugai and Roche is that of MRA: Chugai’s monoclonal antibody in development for the treatment of a number of conditions (eg Rheumatoid Arthritis).
Chugai conducts research at its Japanese research sites employing cutting-edge techniques for identification of small molecule and biological therapeutic candidates.


Mulliner House
Turnham Green
W4 1NN
United Kingdom


Phone: 44 (0) 20 8987 5600
Fax: 44 (0) 20 8987 5660

News Articles [772 Associated News Articles listed on BioPortfolio]

China Accepts Chugai's NDA Submission for Novel Osteoporosis Treatment

Chugai Pharma reported that the CFDA accepted its New Drug Application for eldecalcitol, an oral active vitamin D3 derivative for osteoporosis. A Japanese pharma, Chugai is majority-owned (62%) by Roc...

Roche-Tochter Chugai erhält 184 Mio CHF für Rechte-Transfer von Produkten

Taiyo Pharma habe dafür eine Summe von 21,3 Mrd Yen (rund 184 Mio CHF) bezahlt, teilte Roche-Tochter Chugai am Freitag mit. Auf das finanzielle Ergebnis 2017 von Chugai werde die Transaktion keinen.....

Chiome Bioscience, Chugai Pharma Terminate Partnership

Chiome Bioscience says it announces termination of candidate antibody related joint research contract, which was signed between the co and Chugai Pharma, as the contract has expired on Dec. 31

EU Follows US and Approves Chugai's ALK Inhibitor "Alecensa" as First Line Therapy for ALK-Positive Non-Small Cell Lung Cancer

Alecensa Now Available in Japan, the United States and Europe for the Treatment of Advanced Lung Cancer Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) announced today that F. Hoffmann-La Roche Ltd. ...

BRIEF—Chugai’s Mircera injection syringe 12.5μg approved in Japan

Japanese drug major Chugai Pharmaceutical says it has obtained approval from the Ministry of Health,…

Chugai applies for additional indication for breast cancer drug in Japan

Chugai has filed an application with the Japanese Ministry of Health, Labor and Welfare (MHLW) for the…

China FDA to review Chugai's regulatory submission for Edirol

Shares in Japanese drugmaker Chugai Pharmaceutical are up almost 5% on news that the China Food and Drug…

Chugai's Head of Science and Strategy to Speak at Medtech & Pharma Platform Conference

Chugai Pharma USA, Inc. (CPUSA), a wholly-owned subsidiary of Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) leading the planning and execution of early-stage global clinical...

Drugs and Medications [246 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

PubMed Articles [364 Associated PubMed Articles listed on BioPortfolio]

The genomic history of southeastern Europe.

Farming was first introduced to Europe in the mid-seventh millennium bc, and was associated with migrants from Anatolia who settled in the southeast before spreading throughout Europe. Here, to unders...

Bioanalytical outsourcing: transitioning from Pharma to CRO.

Current Practice of Airway Stenting in the Adult Population in Europe: A Survey of the European Association of Bronchology and Interventional Pulmonology (EABIP).

Airway stenting (AS) commenced in Europe circa 1987 with the first placement of a dedicated silicone airway stent. Subsequently, over the last 3 decades, AS was spread throughout Europe, using differe...

Moving pharma contracting into the era of accountability.

Patent trend and competitive analysis of cancer immunotherapy in the United States.

Immunotherapy has brought high hopes for cancer treatment, and attracted tremendous resources from the biopharmaceutical community. Here we analyze cancer immunotherapy-related patents granted by the ...

Clinical Trials [619 Associated Clinical Trials listed on BioPortfolio]

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

OK432 (Picibanil) in the Treatment of Lymphatic Malformations

Standard of care for Lymphatic Malformations has been surgical excision. We have been using OK432/Picibanil (generously supplied by Chugai Pharmaceuticals in Japan) since 1992 with great s...

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

Identification of Biomarkers Sensitive to Disease Progression in Patients With Mild Cognitive Impairment

THE STUDY WILL BE A TWO-PART RESEARCH PART A and PART A extended: 1. To implement a "common" MRI acquisition protocol in multiple centers across Europe (Pharma-COG partners)...

Companies [1542 Associated Companies listed on BioPortfolio]

Chugai Pharma Europe Limited

European headquarters of Chugai Pharmaceutical Co. Ltd. and Chugai Pharma UK Ltd.

Chugai Pharma Europe Ltd

Chugai Pharmaceutical Co., Ltd is headquartered in Tokyo, Japan. In its home market, Chugai is a household name, with a broad-ranging product portfolio encompassing highly specialised therapeutic anti...

Chugai Pharma USA, Inc.

Astellas Pharma Canada, Inc.

Astellas Pharma Europe Ltd., located in the UK, is the European Headquarters of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the he...

Astellas Pharma Europe Ltd.

Astellas Pharma Europe Ltd., located in the UK, is a European subsidiary of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around...

More Information about "Chugai Pharma Europe Ltd" on BioPortfolio

We have published hundreds of Chugai Pharma Europe Ltd news stories on BioPortfolio along with dozens of Chugai Pharma Europe Ltd Clinical Trials and PubMed Articles about Chugai Pharma Europe Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Chugai Pharma Europe Ltd Companies in our database. You can also find out about relevant Chugai Pharma Europe Ltd Drugs and Medications on this site too.

Quick Search


Relevant Topics

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Corporate Database Quicklinks

Searches Linking to this Company Record